Where Quantum
Artificial Intelligence
Meets Biotechnolgy.
Where Quantum
Artificial Intelligence
Meets Biotechnolgy.
Where Quantum
Artificial Intelligence
Meets Biotechnolgy.
Harnessing the power of quantum computing & AI to revolutionize drug discovery, medical imaging, and personalized medicine.
Harnessing the power of quantum computing & AI to revolutionize drug discovery, medical imaging, and personalized medicine.
Quantum Dance unifies quantum AI and biotech to cut drug discovery from years to months.
introduction
introduction
introduction
introduction
QuantumDance pairs quantum algorithms with high-performance computing and AI to decode biological complexity at scale, turning raw pixels, base pairs, and assay signals into decisions teams can trust.
QuantumDance pairs quantum algorithms with high-performance computing and AI to decode biological complexity at scale, turning raw pixels, base pairs, and assay signals into decisions teams can trust.
QuantumDance pairs quantum algorithms with high-performance computing and AI to decode biological complexity at scale, turning raw pixels, base pairs, and assay signals into decisions teams can trust.
Quantum-First Architecture
Proprietary quantum search explores chemical space far beyond classical heuristics, while HPC-trained models learn the subtle signatures in clinical images and multi-omics matrices that conventional tools miss. The result: deeper exploration, faster iteration, and signals that translate from bench to bedside.
Quantum-First Architecture
Proprietary quantum search explores chemical space far beyond classical heuristics, while HPC-trained models learn the subtle signatures in clinical images and multi-omics matrices that conventional tools miss. The result: deeper exploration, faster iteration, and signals that translate from bench to bedside.
Quantum-First Architecture
Proprietary quantum search explores chemical space far beyond classical heuristics, while HPC-trained models learn the subtle signatures in clinical images and multi-omics matrices that conventional tools miss. The result: deeper exploration, faster iteration, and signals that translate from bench to bedside.
Quantum-First Architecture
Proprietary quantum search explores chemical space far beyond classical heuristics, while HPC-trained models learn the subtle signatures in clinical images and multi-omics matrices that conventional tools miss. The result: deeper exploration, faster iteration, and signals that translate from bench to bedside.
Integrated Discovery Platform
A single spine unifies three pillars; molecular simulation, radiomic feature discovery, and multi-omics pathway mapping, so insights flow across modalities instead of living in silos. One infrastructure, shared security and validation, cloud or on-prem, PACS/EHR-ready.
Integrated Discovery Platform
A single spine unifies three pillars; molecular simulation, radiomic feature discovery, and multi-omics pathway mapping, so insights flow across modalities instead of living in silos. One infrastructure, shared security and validation, cloud or on-prem, PACS/EHR-ready.
Integrated Discovery Platform
A single spine unifies three pillars; molecular simulation, radiomic feature discovery, and multi-omics pathway mapping, so insights flow across modalities instead of living in silos. One infrastructure, shared security and validation, cloud or on-prem, PACS/EHR-ready.
Integrated Discovery Platform
A single spine unifies three pillars; molecular simulation, radiomic feature discovery, and multi-omics pathway mapping, so insights flow across modalities instead of living in silos. One infrastructure, shared security and validation, cloud or on-prem, PACS/EHR-ready.
Who we serve
Who we serve
Who we serve
Who we serve
Built for hospitals, pharma, and research.
Built for hospitals,
pharma, and research.
Built for hospitals,
pharma, and research.
Built for hospitals, pharma, and research.
QuantumDance adapts to your world, plugging into existing tools to deliver earlier signal, faster decisions, and workflows that feel native to care, R&D, and the lab.
QuantumDance adapts to your world, plugging into existing tools to deliver earlier signal, faster decisions, and workflows that feel native to care, R&D, and the lab.
QuantumDance adapts to your world, plugging into existing tools to deliver earlier signal, faster decisions, and workflows that feel native to care, R&D, and the lab.
01
Hospitals
Plug into your existing PACS—no rip-and-replace. Radiomics overlays and clinician-ready reports surface earlier flags so teams move faster and readmissions drop.
01
Hospitals
Plug into your existing PACS—no rip-and-replace. Radiomics overlays and clinician-ready reports surface earlier flags so teams move faster and readmissions drop.
01
Hospitals
Plug into your existing PACS—no rip-and-replace. Radiomics overlays and clinician-ready reports surface earlier flags so teams move faster and readmissions drop.
01
Hospitals
Plug into your existing PACS—no rip-and-replace. Radiomics overlays and clinician-ready reports surface earlier flags so teams move faster and readmissions drop.
02
Pharmaceuticals
Run CTSim™' generate–test–refine loop to explore more space, then stratify cohorts with imaging and predict response sooner—de-risking trials from lead triage to study design.
02
Pharmaceuticals
Run CTSim™' generate–test–refine loop to explore more space, then stratify cohorts with imaging and predict response sooner—de-risking trials from lead triage to study design.
02
Pharmaceuticals
Run CTSim™' generate–test–refine loop to explore more space, then stratify cohorts with imaging and predict response sooner—de-risking trials from lead triage to study design.
02
Pharmaceuticals
Run CTSim™' generate–test–refine loop to explore more space, then stratify cohorts with imaging and predict response sooner—de-risking trials from lead triage to study design.
03
Research
We believe in honesty and transparency in all aspects of our practice. From clear communication about your treatment options to ethical business practices, we strive to build trust with our patients.
03
Research
We believe in honesty and transparency in all aspects of our practice. From clear communication about your treatment options to ethical business practices, we strive to build trust with our patients.
03
Research
We believe in honesty and transparency in all aspects of our practice. From clear communication about your treatment options to ethical business practices, we strive to build trust with our patients.
03
Research
We believe in honesty and transparency in all aspects of our practice. From clear communication about your treatment options to ethical business practices, we strive to build trust with our patients.
Our Products
Our Products
Our Products
Our Products
Three purpose-built engines,
one integrated workflow
Three purpose-built engines, one integrated workflow
Integrated Approach
One spine for molecules, images, and omics, so insights flow, not silo.
Visibility Into Outcomes
Surface hidden signals that change decisions - sooner.
Time-to-response
Cohort comparison
Risk signals
Delta from baseline
Biomarker strength
Readmission risk
Outcome prediction
Biomarker strength
Cohort comparison
Delta from baseline
Confidence score
Risk signals
Time-to-response
Delta from baseline
Cohort comparison
Speed & Accuracy
Quantum + HPC shorten cycles while validated models lift precision.
Integrated Approach
One spine for molecules, images, and omics, so insights flow, not silo.
Visibility Into Outcomes
Surface hidden signals that change decisions - sooner.
Time-to-response
Cohort comparison
Risk signals
Delta from baseline
Biomarker strength
Readmission risk
Outcome prediction
Biomarker strength
Cohort comparison
Delta from baseline
Confidence score
Risk signals
Time-to-response
Delta from baseline
Cohort comparison
Speed & Accuracy
Quantum + HPC shorten cycles while validated models lift precision.
Integrated Approach
One spine for molecules, images, and omics, so insights flow, not silo.
Visibility Into Outcomes
Surface hidden signals that change decisions - sooner.
Time-to-response
Cohort comparison
Risk signals
Delta from baseline
Biomarker strength
Readmission risk
Outcome prediction
Biomarker strength
Cohort comparison
Delta from baseline
Confidence score
Risk signals
Time-to-response
Delta from baseline
Cohort comparison
Speed & Accuracy
Quantum + HPC shorten cycles while validated models lift precision.
Integrated Approach
One spine for molecules, images, and omics, so insights flow, not silo.
Integrated Approach
One spine for molecules, images, and omics, so insights flow, not silo.
Visibility Into Outcomes
Surface hidden signals that change decisions - sooner.
Time-to-response
Cohort comparison
Risk signals
Delta from baseline
Biomarker strength
Readmission risk
Outcome prediction
Biomarker strength
Cohort comparison
Delta from baseline
Confidence score
Risk signals
Time-to-response
Delta from baseline
Cohort comparison
Visibility Into Outcomes
Surface hidden signals that change decisions - sooner.
Time-to-response
Cohort comparison
Risk signals
Delta from baseline
Biomarker strength
Readmission risk
Outcome prediction
Biomarker strength
Cohort comparison
Delta from baseline
Confidence score
Risk signals
Time-to-response
Delta from baseline
Cohort comparison
Speed & Accuracy
Quantum + HPC shorten cycles & validated models lift precision.
Speed & Accuracy
Quantum + HPC shorten cycles & validated models lift precision.
Clinical Validation
Tested on retrospective cohorts; methods available.
Clinical Validation
Tested on retrospective cohorts; methods available.
Clinical Validation
Tested on retrospective cohorts; methods available.
Clinical Validation
Tested on retrospective cohorts; methods available.
Enterprise Security
HIPAA-compliant end-to-end encrypted infrastructure
Enterprise Security
HIPAA-compliant end-to-end encrypted infrastructure
Enterprise Security
HIPAA-compliant end-to-end encrypted infrastructure
Enterprise Security
HIPAA-compliant end-to-end encrypted infrastructure
Workflow Integration
PACS/EHR ready; cloud or on-prem.
Workflow Integration
PACS/EHR ready; cloud or on-prem.
Workflow Integration
PACS/EHR ready; cloud or on-prem.
Workflow Integration
PACS/EHR ready; cloud or on-prem.
Accelerated Discovery
Compress years of research into months or weeks
Accelerated Discovery
Compress years of research into months or weeks
Accelerated Discovery
Compress years of research into months or weeks
Accelerated Discovery
Compress years of research into months or weeks
Redefining Quantum
Redefining Quantum
Redefining Quantum
Redefining Quantum
Born from the collective ambition of industry veterans and technology innovators.
Born from the collective ambition of industry veterans and technology innovators.
Born from the collective ambition of industry veterans and technology innovators.
Industry Recognition
Early traction with 3 pharma LOIs and 10 hospital pilots; clinical validation in progress.
Industry Recognition
Early traction with 3 pharma LOIs and 10 hospital pilots; clinical validation in progress.
Industry Recognition
Early traction with 3 pharma LOIs and 10 hospital pilots; clinical validation in progress.
Industry Recognition
Early traction with 3 pharma LOIs and 10 hospital pilots; clinical validation in progress.
“Internal pilots showed up to 90× faster imaging workflows and 48× faster genomic processing, surfacing candidates missed by conventional screens.”
Dr. Ahmed Fadiel, MS, PhD
Founder Quantum Dance
“Internal pilots showed up to 90× faster imaging workflows and 48× faster genomic processing, surfacing candidates missed by conventional screens.”
Dr. Ahmed Fadiel, MS, PhD
Founder Quantum Dance
“Internal pilots showed up to 90× faster imaging workflows and 48× faster genomic processing, surfacing candidates missed by conventional screens.”
Dr. Ahmed Fadiel, MS, PhD
Founder Quantum Dance
“Internal pilots showed up to 90× faster imaging workflows and 48× faster genomic processing, surfacing candidates missed by conventional screens.”
Dr. Ahmed Fadiel, MS, PhD
Founder Quantum Dance
3-7 day turnaround time
500+ biomarkers identified
>10x faster discovery
3-7 day turnaround time
500+ biomarkers identified
>10x faster discovery
3-7 day turnaround time
500+ biomarkers identified
>10x faster discovery
3-7 day turnaround time
500+ biomarkers identified
>10x faster discovery
Benefits + Features
Benefits + Features
Benefits + Features
Benefits + Features
Built for Real-World Medicine
Built for
Real-World Medicine
Built for
Real-World Medicine
We design for outcomes, not hype. A hybrid quantum–classical stack powers CTSim™, QuantumVision™, and QuantumOmix™ so teams see earlier signal, make clearer decisions, and move from discovery to decision faster.
Hybrid by design
Quantum accelerates complex search and simulation while HPC orchestrates training and inference at scale, seamlessly plugging into lab and clinical workflows for reliable, real-world deployments.
Hybrid by design
Quantum accelerates complex search and simulation while HPC orchestrates training and inference at scale, seamlessly plugging into lab and clinical workflows for reliable, real-world deployments.
Hybrid by design
Quantum accelerates complex search and simulation while HPC orchestrates training and inference at scale, seamlessly plugging into lab and clinical workflows for reliable, real-world deployments.
Hybrid by design
Quantum accelerates complex search and simulation while HPC orchestrates training and inference at scale, seamlessly plugging into lab and clinical workflows for reliable, real-world deployments.
Clinical-grade from day one
Security, encryption, access controls, and data-residency options align with GDPR and HIPAA expectations, preserving privacy & auditability without slowing teams or breaking existing processes.
Clinical-grade from day one
Security, encryption, access controls, and data-residency options align with GDPR and HIPAA expectations, preserving privacy & auditability without slowing teams or breaking existing processes.
Clinical-grade from day one
Security, encryption, access controls, and data-residency options align with GDPR and HIPAA expectations, preserving privacy & auditability without slowing teams or breaking existing processes.
Clinical-grade from day one
Security, encryption, access controls, and data-residency options align with GDPR and HIPAA expectations, preserving privacy & auditability without slowing teams or breaking existing processes.
End-to-end learning loop
Three platforms feed each other; molecule to biomarker to pathway, so insights compound across CTSim™, QuantumVision™, and QuantumOmix™, improving prioritization and reducing waste.
End-to-end learning loop
Three platforms feed each other; molecule to biomarker to pathway, so insights compound across CTSim™, QuantumVision™, and QuantumOmix™, improving prioritization and reducing waste.
End-to-end learning loop
Three platforms feed each other; molecule to biomarker to pathway, so insights compound across CTSim™, QuantumVision™, and QuantumOmix™, improving prioritization and reducing waste.
End-to-end learning loop
Three platforms feed each other; molecule to biomarker to pathway, so insights compound across CTSim™, QuantumVision™, and QuantumOmix™, improving prioritization and reducing waste.
Measurable signal, earlier
Radiomics and multi-omics surface features conventional reads miss, raising sensitivity and confidence so teams can prioritize sooner design smarter trials, and focus effort where impact matters.
Measurable signal, earlier
Radiomics and multi-omics surface features conventional reads miss, raising sensitivity and confidence so teams can prioritize sooner design smarter trials, and focus effort where impact matters.
Measurable signal, earlier
Radiomics and multi-omics surface features conventional reads miss, raising sensitivity and confidence so teams can prioritize sooner design smarter trials, and focus effort where impact matters.
Measurable signal, earlier
Radiomics and multi-omics surface features conventional reads miss, raising sensitivity and confidence so teams can prioritize sooner design smarter trials, and focus effort where impact matters.
Interoperable, not isolated
Works with PACS, LIMS, and data lakes already in place; bring your models and assays, then export clean outputs into downstream tools so scientists and clinicians act without friction.
Interoperable, not isolated
Works with PACS, LIMS, and data lakes already in place; bring your models and assays, then export clean outputs into downstream tools so scientists and clinicians act without friction.
Interoperable, not isolated
Works with PACS, LIMS, and data lakes already in place; bring your models and assays, then export clean outputs into downstream tools so scientists and clinicians act without friction.
Interoperable, not isolated
Works with PACS, LIMS, and data lakes already in place; bring your models and assays, then export clean outputs into downstream tools so scientists and clinicians act without friction.
One Loop.
Three Modalities.
From molecule to biomarker to pathway, the loop transforms images and omics into signal, so teams see more, sooner, and decide with confidence.
One Loop.
Three Signals.
From molecule to biomarker to pathway, the loop transforms images and omics into signal, so teams see more, sooner, and decide with confidence.
One Loop.
Three Signals.
From molecule to biomarker to pathway, the loop transforms images and omics into signal, so teams see more, sooner, and decide with confidence.
One Loop.
Three Modalities.
From molecule to biomarker to pathway, the loop transforms images and omics into signal, so teams see more, sooner, and decide with confidence.
Our Progress
Our Progress
Our Progress
Our Progress
Research to Clinical‑Grade Platforms
Research to Clinical‑Grade Platforms
Research to Clinical‑Grade Platforms
Research to Clinical‑Grade Platforms
1
CTSim™ evolution
From early quantum docking prototypes to CTSim™ v3 with hybrid quantum‑classical pipelines that screen large chemical space and prioritize high‑affinity candidates with greater precision.
1
CTSim™ evolution
From early quantum docking prototypes to CTSim™ v3 with hybrid quantum‑classical pipelines that screen large chemical space and prioritize high‑affinity candidates with greater precision.
1
CTSim™ evolution
From early quantum docking prototypes to CTSim™ v3 with hybrid quantum‑classical pipelines that screen large chemical space and prioritize high‑affinity candidates with greater precision.
1
CTSim™ evolution
From early quantum docking prototypes to CTSim™ v3 with hybrid quantum‑classical pipelines that screen large chemical space and prioritize high‑affinity candidates with greater precision.
2
QuantumVision validation
Progressed from single‑site experiments to multi‑site radiomics studies, producing robust imaging biomarkers and model reproducibility across scanners and protocols.
2
QuantumVision validation
Progressed from single‑site experiments to multi‑site radiomics studies, producing robust imaging biomarkers and model reproducibility across scanners and protocols.
2
QuantumVision validation
Progressed from single‑site experiments to multi‑site radiomics studies, producing robust imaging biomarkers and model reproducibility across scanners and protocols.
2
QuantumVision validation
Progressed from single‑site experiments to multi‑site radiomics studies, producing robust imaging biomarkers and model reproducibility across scanners and protocols.
3
QuantumOmix at scale
Advanced from small cohorts to multi‑omics graphs handling large datasets, mapping variant to pathway relationships and enabling target discovery and patient stratification.
3
QuantumOmix at scale
Advanced from small cohorts to multi‑omics graphs handling large datasets, mapping variant to pathway relationships and enabling target discovery and patient stratification.
3
QuantumOmix at scale
Advanced from small cohorts to multi‑omics graphs handling large datasets, mapping variant to pathway relationships and enabling target discovery and patient stratification.
3
QuantumOmix at scale
Advanced from small cohorts to multi‑omics graphs handling large datasets, mapping variant to pathway relationships and enabling target discovery and patient stratification.
4
Compliance and reliability
Moved from research sandboxes to enterprise deployments with audit trails, access controls, and HIPAA/GDPR‑ready data handling across imaging and omics workflows.
4
Compliance and reliability
Moved from research sandboxes to enterprise deployments with audit trails, access controls, and HIPAA/GDPR‑ready data handling across imaging and omics workflows.
4
Compliance and reliability
Moved from research sandboxes to enterprise deployments with audit trails, access controls, and HIPAA/GDPR‑ready data handling across imaging and omics workflows.
4
Compliance and reliability
Moved from research sandboxes to enterprise deployments with audit trails, access controls, and HIPAA/GDPR‑ready data handling across imaging and omics workflows.
5
Partnered deployments
Expanded from proof‑of‑concepts to active collaborations with pharma and research hospitals, delivering APIs that integrate with LIMS, EHR, and PACS for end‑to‑end workflows.
5
Partnered deployments
Expanded from proof‑of‑concepts to active collaborations with pharma and research hospitals, delivering APIs that integrate with LIMS, EHR, and PACS for end‑to‑end workflows.
5
Partnered deployments
Expanded from proof‑of‑concepts to active collaborations with pharma and research hospitals, delivering APIs that integrate with LIMS, EHR, and PACS for end‑to‑end workflows.
5
Partnered deployments
Expanded from proof‑of‑concepts to active collaborations with pharma and research hospitals, delivering APIs that integrate with LIMS, EHR, and PACS for end‑to‑end workflows.
Our Performance
Our Performance
Our Performance
Our Performance
Proven Traction Across Discovery and Clinical Validation
Proven Traction Across Discovery and Clinical Validation
Proven Traction Across Discovery and Clinical Validation
Early-Stage Results That Signal Market Readiness
Proven results across pilot programs, proof-of-concept validation, and strategic partnerships. Our platforms deliver measurable improvements in drug discovery speed, diagnostic accuracy, and biomarker identification - backed by early traction with pharmaceutical companies and healthcare providers.
Early-Stage Results That Signal Market Readiness
Proven results across pilot programs, proof-of-concept validation, and strategic partnerships. Our platforms deliver measurable improvements in drug discovery speed, diagnostic accuracy, and biomarker identification - backed by early traction with pharmaceutical companies and healthcare providers.
Early-Stage Results That Signal Market Readiness
Proven results across pilot programs, proof-of-concept validation, and strategic partnerships. Our platforms deliver measurable improvements in drug discovery speed, diagnostic accuracy, and biomarker identification - backed by early traction with pharmaceutical companies and healthcare providers.
Early-Stage Results That Signal Market Readiness
Proven results across pilot programs, proof-of-concept validation, and strategic partnerships. Our platforms deliver measurable improvements in drug discovery speed, diagnostic accuracy, and biomarker identification - backed by early traction with pharmaceutical companies and healthcare providers.
Trust built into
every step.
Trust built into every step.
Trust built into
every step.
Trust built into every step.
Built for healthcare realities: encryption in transit and at rest, granular access controls, audit trails, and data-residency options.
Built for healthcare realities: encryption in transit and at rest, granular access controls, audit trails, and data-residency options.
GDPR, CCPA & EUAI Compliant
GDPR, CCPA & EUAI Compliant
GDPR, CCPA & EUAI Compliant
GDPR, CCPA & EUAI Compliant
HIPAA Compliant
HIPAA Compliant
HIPAA Compliant
HIPAA Compliant
GDPR-ready
EU data rights honored; DPA available.
GDPR-ready
EU data rights honored; DPA available.
GDPR-ready
EU data rights honored; DPA available.
GDPR-ready
EU data rights honored; DPA available.
HIPAA-aligned
PHI safeguards; BAA on request.
HIPAA-aligned
PHI safeguards; BAA on request.
HIPAA-aligned
PHI safeguards; BAA on request.
HIPAA-aligned
PHI safeguards; BAA on request.
Data residency
EU / US / UAE regional control.
Data residency
EU / US / UAE regional control.
Data residency
EU / US / UAE regional control.
Data residency
EU / US / UAE regional control.
Audit & access
RBAC, SSO/OIDC, full logs.
Audit & access
RBAC, SSO/OIDC, full logs.
Audit & access
RBAC, SSO/OIDC, full logs.
Audit & access
RBAC, SSO/OIDC, full logs.
Impressive metrics
Latest News
Impressive metrics
Latest News
Impressive metrics
Latest News
Impressive metrics
Latest News
Frequently Asked Questions
Frequently Asked Questions
Frequently Asked Questions
Frequently Asked Questions
Everything you need to know about accelerating discovery with quantum algorithms.
Everything you need to know about accelerating discovery with quantum algorithms.
Everything you need to know about accelerating discovery with quantum algorithms.
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.
What systems does the platform integrate with?
How accurate are the biomarker predictions?
How do you handle confidential data?
What's the typical timeline for results?
What technical expertise is needed?
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.
What systems does the platform integrate with?
How accurate are the biomarker predictions?
How do you handle confidential data?
What's the typical timeline for results?
What technical expertise is needed?
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.
What systems does the platform integrate with?
How accurate are the biomarker predictions?
How do you handle confidential data?
What's the typical timeline for results?
What technical expertise is needed?
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.